Content Search

BIOMARKERS AND PERSONALIZED MEDICINE IN PROSTATE CANCER – ADVENT OF PRECISION ONCOLOGY IN (RADIO)THERAPY DECISION-MAKING

Antonela Njavro, Jure Murgić, Blanka Jakšić, Marin Prpić, Angela Prgomet Sečan, Dora Franceschi, Marija Miletić, Slaven Ovčariček, Adelina Hrkač, Ivan Šamija, Monika Ulamec, Marijana Jazvić, Pero Bokarica, Igor Tomašković and Ana Fröbe

CURRENT STATE OF EVIDENCE AND PRACTICE OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) IMAGING ACROSS THE PROSTATE CANCER CLINICAL LANDSCAPE – ONCOLOGIST PERSPECTIVE

Antonela Njavro, Jure Murgić, Blanka Jakšić, Marin Prpić, Angela Prgomet Sečan, Dražen Huić, Dinko Franceschi and Ana Fröbe

PROSTATE CANCER THERANOSTICS – CURRENT EVIDENCE AND FUTURE CONSIDERATIONS: A BRIEF OVERVIEW

Antonela Njavro, Jure Murgić, Blanka Jakšić, Marin Prpić, Angela Prgomet Sečan, Dražen Huić, Dinko Franceschi and Ana Fröbe

A NEW PARADIGM IN THE SYSTEMIC TREATMENT OF ADVANCED PROSTATE CANCER: THE EARLIER THE BETTER OR THE MORE THE BETTER

Tomislav Omrčen and Jure Murgić